Poster SESSIONS
67
Poster, 24 June 2014
Authors are asked to present their posters during the poster sessions.
P-32
POSTER SESSION
17:15–18:45
Hall B
Biomarkers (incl. Pharmacogenomics and
brain imaging) for diagnosis and treat-
ment response B
P-32-001
Altered face inversion effect in schizo-
phrenic patients treated with typical vs
atypical antipsychotics
Tomoya Tsunoda, Tokorozawa, Japan
M. Uenoyama, S. Nomura, H. Toda, M. Naga-
mine, K. Shimizu
P-32-002
Proteomic analysis of the lymphoblastoid cell
line derived from Japanese schizophrenic
patients
Akira Yoshimi, Nagoya, Japan
S. Kunimoto, S. Yamada, B. Aleksic, A. Hiraka-
wa, T. Nagai, N. Ozaki
P-32-003
Effects of NSI-189, a neurogenic compound,
on quantitative electroencephalography
(qEEG) in patients with major depressive
disorder (MDD) during a phase 1b random-
ized, double-blind, placebo controlled, mul-
tiple ascending dose study
Brett English, Glendale, USA
J. Johnstone, K. Johe, L. Gertsik, M. Sherman,
M. Fava, L. Ereshefsky
P-32-004
Basal prolactin levels as a predictor of re-
sponse to antidepressant treatment
Agata Faron-Górecka, Krakow, Poland
M. Kusmider, K. Szafran, M. Kolasa, P. Gruca,
M. Papp, D. Zurawek, J. Solich, P. Pabian, M.
Dziedzicka-Wasylewska
P-32-005
Adverse drug reactions and CYP2D6 geno-
types in patients with mood disorders
Amanda Holck, Lund, Sweden
A.-L. Zackrisson, M. Reis, Å. Westrin
P-32-006
Investigation of dopaminergic and seroto-
nergic receptors for their association with
antipsychotic response in north Indian
schizophrenia patients
Ajay Jajodia, Delhi, India
H. Kaur, R. Chadda, K. Kumari, S. Jain, R. Kukreti
P-32-007
PAPA–Pharmacokinetics in pregnancy and
antidepressant drugs
Ann Josefsson, Linköping, Sweden
M. Reis
P-32-008
A deep sequencing study of circulating mi-
croRNA levels in peripheral whole blood fol-
lowing ECT for severe depression
Erik Kolshus, Dublin, Ireland
G. Blackshields, D. McLoughlin, K. Ryan
P-33
POSTER SESSION
17:15–18:45
Hall B
Psychoneuroimmunology and neuroinflam-
mation B
P-33-001
A cytokine study in children and adolescents
with tic disorders and/or OCD
Taewon Park, Jeonju-Si, Republic of Korea
Y. W. Jung
P-33-002
CCL2 is associated with hippocampal and
amygdala volume in females with major de-
pressive disorder
Jonathan Savitz, Tulsa, USA
W. Drevets, C. Smith, T. Victor, B. Wurfel, P. Bell-
gowan, J. Bodurka, K. Teague, R. Dantzer
P-33-003
Effects of mood-modulating drugs on lipo-
polysaccharide-induced hypothermia and
elevation in plasma cytokines levels in rats
Yael Sharon-Granit, Beer-Sheva, Israel
A. Nassar, A. N. Azab
P-34
POSTER SESSION
17:15–18:45
Hall B
Autism spectrum disorders B
P-34-001
Mouse models of tuberous sclerosis complex
show autism-related behavioral deficits se-
verer in Tsc2 than Tsc1 haploinsufficiency
Atsushi Sato, Tokyo, Japan
Y. Takamatsu, S. Kasai, T. Kobayashi, O. Hino,
K. Ikeda, M. Mizuguchi
P-34-002
A higher ratio of omega-6 /omega-3 fatty
acid remarkably improved the core symp-
tom of autism spectrum disorders via up-
regulation of signaling: Comparison with
risperidone solution
Kunio Yui, Ashiya, Japan
H. Yamanouchi
